Alimentary Pharmacology and Therapeutics 2012-10-01

Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations.

A Repici, R Cestari, V Annese, G Biscaglia, E Vitetta, L Minelli, G Trallori, S Orselli, A Andriulli, C Hassan

Index: Aliment. Pharmacol. Ther. 36(8) , 717-24, (2012)

Full Text: HTML

Abstract

Low-volume bowel preparations with polyethylene glycol (PEG) have been shown to provide an equivalent cleansing with improved tolerability as compared with standard PEG bowel preparation for colonoscopy. A new iso-osmotic sulphate-free formulation of PEG-Citrate-Simethicone (PEG-CS) in combination with bisacodyl has been recently developed.To compare the quality of bowel cleansing with PEG-CS with bisacodyl vs. PEG-Ascorbate (PEG-ASC) in adult out-patients undergoing colonoscopy.Randomised, observer-blind, parallel group study in adult out-patients undergoing colonoscopy in five Italian centres. Both preparations were taken the evening before the procedure. Subjects were instructed to take 2-4 tablets of 5 mg bisacodyl at 16:00 hours and 2 L of PEG-CS at 20:00 hours or 2 L of PEG-ASC plus 1 L of additional water the day before colonoscopy. Bowel cleansing was evaluated according to the Boston Bowel Preparation Scale (≥6 scores were considered as 'clinical success'), and mucosal visibility according to a 3-point scale. Tolerability, acceptability and compliance were also evaluated.Four hundred and eight patients were randomly allocated to PEG-CS and bisacodyl (n = 204, male patient 48%, mean age 59.1 years) or PEG-ASC (n = 204, male patient 51%, age 59.4 years). In the planned per-protocol analysis, the rate of successful preparation was 79.1% following PEG-CS with bisacodyl, and 70% following PEG-ASC (P < 0.05). Mucosal visibility was evaluated as optimal in 56.1% in the PEG-CS and bisacodyl and 46.3% in the PEG-ASC group (P < 0.05). There were no serious adverse events (AE) in each of the two experimental groups. Two subjects in the PEG-ASC group discontinued the study because of AE.Polyethylene glycol-Citrate-Simethicone in combination with bisacodyl was more effective for bowel cleansing than PEG-ASC for out-patient colonoscopy. Tolerability, safety, acceptability and compliance of the two low-volume bowel preparations were similar.© 2012 Blackwell Publishing Ltd.


Related Compounds

Related Articles:

[Bowel preparation for colonoscopy: comparative study using Boston Bowel Preparation Scale].

2012-09-01

[Acta Gastroenterol. Latinoam. 42(3) , 186-92, (2012)]

Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.

2011-05-16

[Int. J. Pharm. 409(1-2) , 9-18, (2011)]

Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer.

2014-10-01

[Gastroenterology 147(4) , 903-24, (2014)]

Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the U.S. multi-society task force on colorectal cancer.

2014-10-01

[Gastrointest. Endosc. 80(4) , 543-62, (2014)]

Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.

2015-03-01

[Neurogastroenterol. Motil. 27(3) , 397-405, (2015)]

More Articles...